These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22208973)

  • 21. Prone breast forward intensity-modulated radiotherapy for Asian women with early left breast cancer: factors for cardiac sparing and clinical outcomes.
    Chen JL; Cheng JC; Kuo SH; Chan HM; Huang YS; Chen YH
    J Radiat Res; 2013 Sep; 54(5):899-908. PubMed ID: 23504450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation.
    Leonard KL; Hepel JT; Hiatt JR; Dipetrillo TA; Price LL; Wazer DE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):623-9. PubMed ID: 22867895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS).
    Kraus-Tiefenbacher U; Sfintizky A; Welzel G; Simeonova A; Sperk E; Siebenlist K; Mai S; Wenz F
    Radiat Oncol; 2012 Dec; 7():217. PubMed ID: 23249653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.
    Arthur DW; Winter KA; Kuerer HM; Haffty BG; Cuttino LW; Todor DA; Simone NL; Hayes SB; Woodward WA; McCormick B; Cohen RJ; Sahijdak WM; Canaday DJ; Brown DR; Currey AD; Fisher CM; Jagsi R; White J
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1028-1035. PubMed ID: 28721885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy.
    Berrang TS; Olivotto I; Kim DH; Nichol A; Cho BC; Mohamed IG; Parhar T; Wright JR; Truong P; Tyldesley S; Sussman J; Wai E; Whelan T
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1220-7. PubMed ID: 20971571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary toxicity results using partial breast 3D-CRT with once daily hypo-fractionation and deep inspiratory breath hold.
    Kowalchuk RO; Romano KD; Trifiletti DM; Dutta SW; Showalter TN; Morris MM
    Radiat Oncol; 2018 Jul; 13(1):135. PubMed ID: 30053864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prone breast intensity modulated radiation therapy: 5-year results.
    Osa EO; DeWyngaert K; Roses D; Speyer J; Guth A; Axelrod D; Fenton Kerimian M; Goldberg JD; Formenti SC
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):899-906. PubMed ID: 24867535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
    Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying patients who are unsuitable for accelerated partial breast irradiation using three-dimensional external beam conformal techniques.
    Shikama N; Nakamura N; Kunishima N; Hatanaka S; Sekiguchi K
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e313-8. PubMed ID: 22417799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).
    Bourgier C; Pichenot C; Verstraet R; El Nemr M; Heymann S; Biron B; Delaloge S; Mathieu MC; Garbay JR; Bourhis J; Taghian AG; Marsiglia H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1228-35. PubMed ID: 20932662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis.
    Grann A; McCormick B; Chabner ES; Gollamudi SV; Schupak KD; Mychalczak BR; Heerdt AS; Merchant TE; Hunt MA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):319-25. PubMed ID: 10802355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial.
    Liss AL; Ben-David MA; Jagsi R; Hayman JA; Griffith KA; Moran JM; Marsh RB; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):96-102. PubMed ID: 24613813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions.
    Mulliez T; Veldeman L; van Greveling A; Speleers B; Sadeghi S; Berwouts D; Decoster F; Vercauteren T; De Gersem W; Van den Broecke R; De Neve W
    Radiother Oncol; 2013 Aug; 108(2):203-8. PubMed ID: 24044803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413.
    Wen B; Hsu H; Formenti-Ujlaki GF; Lymberis S; Magnolfi C; Zhao X; Chang J; DeWyngaert JK; Jozsef G; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):910-6. PubMed ID: 22543213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer.
    Lewin AA; Derhagopian R; Saigal K; Panoff JE; Abitbol A; Wieczorek DJ; Mishra V; Reis I; Ferrell A; Moreno L; Takita C
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2104-10. PubMed ID: 21640490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients.
    Lymberis SC; deWyngaert JK; Parhar P; Chhabra AM; Fenton-Kerimian M; Chang J; Hochman T; Guth A; Roses D; Goldberg JD; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):902-9. PubMed ID: 22494590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.
    Horst KC; Fasola C; Ikeda D; Daniel B; Ognibene G; Goffinet DR; Dirbas FM
    Breast; 2016 Aug; 28():178-83. PubMed ID: 27322859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma.
    Rabinovitch R; Moughan J; Vicini F; Pass H; Wong J; Chafe S; Petersen I; Arthur DW; White J
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1054-1059. PubMed ID: 27869081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients.
    Dorn PL; Corbin KS; Al-Hallaq H; Hasan Y; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):79-83. PubMed ID: 22035661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Toxicity and Cosmetic Outcomes After Accelerated Partial Breast Irradiation or Whole Breast Irradiation Using 3-Dimensional Conformal External Beam Radiation Therapy.
    Yadav BS; Loganathan S; Sharma SC; Singh R; Dahiya D
    Adv Radiat Oncol; 2020; 5(2):171-179. PubMed ID: 32280816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.